头部与心脏：ARNI的潜在长期副作用 - Suppr

The Head and the Heart: Potential Long-Term Side Effect of ARNI.

作者信息

Krittanawong Chayakrit, Kitai Takeshi

出版信息

J Am Coll Cardiol. 2017 Apr 11;69(14):1879-1880. doi: 10.1016/j.jacc.2016.12.043.

DOI:10.1016/j.jacc.2016.12.043

PMID:28385323

Abstract

摘要

相似文献

The Head and the Heart: Potential Long-Term Side Effect of ARNI.

J Am Coll Cardiol. 2017 Apr 11;69(14):1879-1880. doi: 10.1016/j.jacc.2016.12.043.

Potential Mortality Reduction With Optimal Implementation of Angiotensin Receptor Neprilysin Inhibitor Therapy in Heart Failure.

JAMA Cardiol. 2016 Sep 1;1(6):714-7. doi: 10.1001/jamacardio.2016.1724.

Early impact of guideline publication on angiotensin-receptor neprilysin inhibitor use among patients hospitalized for heart failure.

Am Heart J. 2018 Jun;200:134-140. doi: 10.1016/j.ahj.2018.01.009. Epub 2018 Jan 31.

Soluble neprilysin does not correlate with outcome in heart failure with preserved ejection fraction?

Eur J Heart Fail. 2016 May;18(5):576. doi: 10.1002/ejhf.538.

Angiotensin Receptor-Neprilysin Inhibition in Heart Failure With Reduced Ejection Fraction: A Paradigm for All?

JACC Heart Fail. 2016 Oct;4(10):823-825. doi: 10.1016/j.jchf.2016.07.013. Epub 2016 Sep 7.

Reply: An Opportunity to Definitively Evaluate the Theoretical Risks of Neprilysin Inhibition.

JACC Heart Fail. 2017 Nov;5(11):852-853. doi: 10.1016/j.jchf.2017.08.008.

An Opportunity to Definitively Evaluate the Theoretical Risks of Neprilysin Inhibition.

JACC Heart Fail. 2017 Nov;5(11):851-852. doi: 10.1016/j.jchf.2017.08.001.

Is there a place for a dual angiotensin receptor-neprilysin inhibitor in the treatment of hypertension?

J Hypertens. 2017 Apr;35(4):726-728. doi: 10.1097/HJH.0000000000001223.

Letter by Rajapakse et al Regarding Article, "Combined Angiotensin Receptor Antagonism and Neprilysin Inhibition".

Circulation. 2016 Jul 19;134(3):e9-e10. doi: 10.1161/CIRCULATIONAHA.116.023086.

Response by Hubers and Brown to Letter Regarding Article, "Combined Angiotensin Receptor Antagonism and Neprilysin Inhibition".

Circulation. 2016 Jul 19;134(3):e11-2. doi: 10.1161/CIRCULATIONAHA.116.023311.

引用本文的文献

Cross talk on therapeutic strategies: natriuretic peptides and inhibiting neprilysin in hypertension management.

Hypertens Res. 2025 Jan;48(1):284-300. doi: 10.1038/s41440-024-01989-w. Epub 2024 Nov 14.

Effects of switching from sacubitril/valsartan to valsartan alone on plasma levels of natriuretic peptides and myocardial remodeling in heart failure with reduced ejection fraction.

BMC Cardiovasc Disord. 2023 Jan 21;23(1):39. doi: 10.1186/s12872-023-03077-2.

Effect of Sacubitril/Valsartan on Neurocognitive Function: Current Status and Future Directions.

Am J Cardiovasc Drugs. 2021 May;21(3):267-270. doi: 10.1007/s40256-020-00445-7. Epub 2020 Oct 16.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验

The Head and the Heart: Potential Long-Term Side Effect of ARNI.

作者信息

出版信息

相似文献

引用本文的文献

文献AI研究员

用中文搜PubMed

文档翻译

Suppr 超能文献

相似文献

引用本文的文献